Subscribe to RSS
DOI: 10.1055/s-0029-1219378
Unusual Product from Condensative Cyclization: Pyrano[3,2-f]quinolin-3,10-diones from 6-Amino-5-[(trimethylsilyl)ethynyl]-2H-chromen-2-one and Aryl Aldehydes
Publication History
Publication Date:
08 February 2010 (online)
Abstract
A new efficient and simple route for the synthesis of 8,9-dihydro-3H-pyrano[3,2-f]quinoline-3,10(7H)-dione derivatives has been accomplished via sulfuric acid promoted condensation-cyclization of 6-amino-5-[(trimethylsilyl)ethynyl]-2H-chromen-2-one and aromatic aldehydes. The products can be oxidized to the corresponding 10-methoxy-8-aryl-3H-pyrano[3,2-f]quinolin-3-one derivatives by FeCl3˙6H2O in methanol.
Key words
condensation-cyclization - 8,9-dihydro-3H-pyrano[3,2-f]-quinoline-3,10(7H)-dione - iron(III) chloride - 10-methoxy-8-phenyl-3H-pyrano[3,2-f]quinolin-3-one
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Elderfield RC. In Heterocyclic Compounds Vol. 4:Elderfield RC. John Wiley; New York/London: 1960. Chap. 1. p.1 -
1b
Kournetsov VV.Mendez LYV.Gomez CMM. Curr. Org. Chem. 2005, 9: 141 -
1c
Bringmann G.Reichert Y.Kane V. Tetrahedron 2004, 60: 3539 -
1d
Sahu NS.Pal C.Mandal NB.Banerjee S.Raha M.Kundu AP.Basu A.Ghosh M.Roy K.Bandopadhyay S. Bioorg. Med. Chem. 2002, 10: 1687 -
1e
Wright CW.Addac-Kyereme J.Breen AG.Brown JE.Cox MF.Croft SL.Gokeck Y.Kendrick H.Phillips RM.Pollet PL. J. Med. Chem. 2001, 44: 3187 -
2a
Prakash O.Kumar D.Saini RK.Singh SP. Synth. Commun. 1994, 24: 2167 -
2b
Singh OV.Kapil RS. Synth. Commun. 1993, 23: 277 -
2c
Kalinin VN.Shostakovsky MV.Ponomaryov AB. Tetrahedron Lett. 1992, 33: 373 -
2d
Xia Y.Yang Z.-Y.Xia P.Bastow KF.Tachibana Y.Kuo S.-C.Hamel E.Hackl T.Lee K.-H. J. Med. Chem. 1998, 41: 1155 - 3
Antimalarial
Drugs II
Peters W.Richards WHG. Springer; Berlin: 1984. -
4a
Maguire MP.Sheets KR.McVety K.Spada AP.Zilberstein A. J. Med. Chem. 1994, 37: 2129 -
4b
Kalluraya B.Sreenivasa S. Farmaco 1998, 53: 399 -
4c
Dube D.Blouin M.Brideau C.Chan C.-C.Desmarais S.Ethier D.Falgueyret J.-P.Friesen RW.Girard M.Girard Y.Guay J.Riendeau D.Tagari P.Young RN. Bioorg. Med. Chem. Lett. 1998, 8: 1255 -
4d
Roma G.Braccio MD.Grossi G.Mattioli F.Ghia H. Eur. J. Med. Chem. 2000, 35: 1021 -
4e
Benkovic SJ.Baker SJ.Alley MRK.Woo Y.-H.Zhang Y.-K.Akama T.Mao W.Baboval J.Rajagopalan PTR.Wall M.Kahng LS.Tavassoli A.Shapiro L. J. Med. Chem. 2005, 48: 7468 -
4f
Vargas LY.Castelli MV.Kouznetsov VV.Urbina JM.Lopez SN.Sortino M.Enriz RD.Ribas JC.Zacchino S. Bioorg. Med. Chem. 2003, 11: 1531 -
4g
Dassonneville L.Bonjean K.De Pauw-Gillet M.-C.Colson P.Houssier C.Quetin-Leclercq J.Angenot L.Ablordeppey SY. Bioorg. Med. Chem. 2002, 10: 1337 -
5a
Goodwin S.Smith AF.Valsquez AA.Horning EC. J. Am. Chem. Soc. 1959, 81: 6209 -
5b
Fournet A.Vagneur B.Rilchomme P.Bruneton J. Can. J. Chem. 1989, 67: 2116 - 6
Ko T.-C.Hour M.-J.Lien J.-C.Teng C.-M.Lee K.-H.Kuo S.-C.Huang L.-J. Bioorg. Med. Chem. Lett. 2001, 11: 279 -
7a
Michael JP. Nat. Prod. Rep. 2000, 17: 603 -
7b
Michael JP. Nat. Prod. Rep. 2004, 21: 650 -
8a
Marco JL.Carreiras MC. J. Med. Chem. 2003, 6: 518 -
8b
Puricelli L.Innocenti G.Delle Monache G.Caniato R.Filippini R.Cappelletti EM. Nat. Prod. Lett. 2002, 16: 95 -
8c
Corral RA.Orazi OO. Tetrahedron Lett. 1967, 7: 583 -
8d
Sekar M.Rejendra Prasad KJ. J. Nat. Prod. 1998, 61: 294 -
9a
Donnelly JA.Farrell DF. Tetrahedron 1990, 46: 885 -
9b
Donnelly JA.Farrell DF. J. Org. Chem. 1990, 55: 1757 -
9c
Tokes AL.Litkei G. Synth. Commun. 1993, 23: 895 -
9d
Varma RS.Sani RK. Synlett 1997, 857 -
9e
Kumar KH.Muralidharan D.Perumal PT. Synthesis 2004, 63 -
9f
Ahmed N.van Lier JE. Tetrahedron Lett. 2006, 47: 2725 -
9g
Ahmed N.van Lier JE. Tetrahedron Lett. 2007, 48: 13 -
9h
Kumar KH.Perumal PT. Can. J. Chem. 2006, 84: 1079 -
9i
Chandrasekhar S.Vijeender K.Sridhar C. Tetrahedron Lett. 2007, 48: 4935 -
9j
Kumar D.Patel G.Kumar A.Roy RK. J. Heterocycl. Chem. 2009, 46: 791 -
10a
Singh OV.Kapil RS. Synlett 1992, 751 -
10b
Verma RS.Kumar D. Tetrahedron Lett. 1998, 39: 9113 -
10c
Mphahlele MJ.Mogamisi FK.Tsanwani M.Hlatshwayo MS.Mampa MR. J. Chem. Res., Synop. 1999, 706 -
10d
Arcadi A.Marinelli F.Rossi E. Tetrahedron 1999, 55: 13233 -
10e
Kumar KH.Perumal PT. Tetrahedron 2007, 63: 9531 -
10f
Kumar KH.Muralidharan D.Perumal PT. Tetrahedron Lett. 2004, 45: 7903 -
10g
Wang Y.Peng C.Liu L.Zhao J.Su L.Zhu Q. Tetrahedron Lett. 2009, 50: 2261 -
11a
Goodwin S.Smith AF.Horning EC. J. Am. Chem. Soc. 1957, 79: 2239 -
11b
Elderfield EC.White JB. J. Am. Chem. Soc. 1946, 68: 1276 -
12a
Tokes AL.Szilagyi L. Synth. Commun. 1987, 17: 1235 -
12b
Tokes AL.Litkei G.Szilagyi L. Synth. Commun. 1992, 22: 2433 -
13a
Singh OV.Kapil RS. Synlett 1992, 751 -
13b
Varma RS.Kumar D. Tetrahedron Lett. 1998, 39: 9113 -
14a
Majumdar KC.Taher A.Debnath P. Synthesis 2009, 793 -
14b
Majumdar KC.Chattopadhyay B.Taher A. Synthesis 2007, 3647 -
14c
Majumdar KC.Debnath P.Taher A. Lett. Org. Chem. 2008, 5: 169 - 15
Majumdar KC.Mondal S. Tetrahedron Lett. 2008, 49: 2418
References and Notes
General Procedure for the Preparation of Compound 5a A mixture of 6-amino-5-[(trimethylsilyl)ethynyl]-2H-chromen-2-one (3, 50 mg, 0.194 mmol), benzaldehyde (4a, 21 mg, 0.194 mmol) and concd H2SO4 (19 mg, 0.194 mmol) was refluxed in MeOH for 2.5 h. After completion of the reaction as monitored by TLC, the reaction mixture was cooled, and the solvent was removed under vacuum and diluted with H2O (50 mL). The mixture was extracted with EtOAc (3 × 25 mL). The combined organic extract was washed with a sat. solution of NaHCO3, followed by brine solution, and dried over anhyd Na2SO4. The solvent was distilled off. The crude product was purified by column chromatography over silica gel (60-120 mesh) using PE-EtOAc (75:25) mixture as eluent to give 8-phenyl-8,9-dihydro-3H-pyrano[3,2-f]quinoline-3,10 (7H)-dione (5a); yield 77%, orange color solid; mp 160-162 ˚C. IR (KBr): νmax = 1299, 1656, 1713, 3318 cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 2.72-2.78 (m, 1 H), 2.87 (dd, J = 14.0, 16.0 Hz, 1 H), 4.69 (s, 1 H), 4.71 (dd, J = 4.0, 14.0 Hz, 1 H), 6.41 (d, J = 10.0 Hz, 1 H), 6.83 (d, J = 9.2 Hz, 1 H), 7.25 (d, J = 9.2 Hz, 1 H), 7.28-7.40 (m, 5 H), 9.28 (d, J = 10.0 Hz, 1 H) ppm. ¹³C NMR (100 MHz): δ = 47.1, 58.0, 110.7, 117.8, 118.2, 120.9, 124.4, 126.5, 128.7, 129.1, 140.0, 142.1, 148.0, 150.1, 160.3, 194.3 ppm. MS: m/z = 292.1 [M + H]+. Anal. Calcd (%) for C18H13NO3: C, 74.22; H, 4.50; N, 4.81. Found: C, 74.49; H, 4.43; N, 4.70.
17General Procedure for the Preparation of Compound 6a A solution of 8-phenyl-8,9-dihydro-3H-pyrano[3,2-f]quinoline-3,10 (7H)-dione (5a, 50 mg, 0.172 mmol) in MeOH (15 mL), FeCl3˙6H2O (116 mg, 0.430 mmol) was added, and the mixture was refluxed on a water bath for 4 h. After completion of the reaction as monitored by TLC, the reaction mixture was cooled and diluted with H2O (50 mL). This was extracted with EtOAc (3 × 25 mL). The combined organic extract was washed with brine solution and dried over anhyd Na2SO4. The solvent was distilled off. The resulting crude product was purified by column chromatog-raphy over silica gel (60-120 mesh) using PE-EtOAc mixture (1:1) as eluent to give 10-methoxy-8-phenyl-3H-pyrano[3,2-f]quinolin-3-one (6a); yield 99%; pale yellow solid; mp 224-226 ˚C. IR (KBr): νmax = 1297, 1563, 1704, 3356 cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 4.22 (s, 3 H), 6.52 (d, J = 10.0 Hz, 1 H), 7.40 (s, 1 H), 7.47-7.57 (m, 3 H), 7.67 (d, J = 9.2 Hz, 1 H), 8.12-8.15 (m, 2 H), 8.26 (d, J = 9.6 Hz, 1 H), 9.31 (d, J = 10.0 Hz, 1 H) ppm. ¹³C NMR (100 MHz, CDCl3): δ = 55.9, 100.7, 113.1, 115.2, 115.4, 121.0, 127.3, 128.9, 129.7, 134.7, 139.0, 143.8, 147.5, 153.9, 158.1, 160.3, 164.3 ppm. HRMS: m/z calcd for C19H13NO3 [M + H]+: 304.0968; found: 304.0938.